Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1750 of 3546 entries
View as:

The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT00338338 Org: User:
Start: 11/07/05 End: 09/14/07 Due: 09/14/08

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Phase: N/A Priority: Normal
NCT ID: NCT01381575 Org: User:
Start: 06/29/11 End: 11/13/14 Due: 11/13/15

A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

Phase: N/A Priority: Normal
NCT ID: NCT01395004 Org: User:
Start: 11/30/11 End: 11/30/13 Due: 11/30/14

Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

Phase: N/A Priority: Normal
NCT ID: NCT01914770 Org: User:
Start: 07/31/09 End: 11/30/10 Due: 11/30/11

Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.

Phase: N/A Priority: Normal
NCT ID: NCT01424462 Org: User:
Start: 04/19/10 End: 07/06/10 Due: 07/06/11

A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India

Phase: N/A Priority: Normal
NCT ID: NCT05648357 Org: User:
Start: 12/14/23 End: 02/26/24 Due: 02/26/25

A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers

Phase: N/A Priority: Normal
NCT ID: NCT03541044 Org: User:
Start: 06/18/18 End: 03/24/19 Due: 03/24/20

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

Phase: N/A Priority: Normal
NCT ID: NCT00079911 Org: User:
Start: 03/12/04 End: 10/15/04 Due: 10/15/05

Disturbed Sleep Model Study.

Phase: N/A Priority: Normal
NCT ID: NCT00440323 Org: User:
Start: 01/05/07 End: 07/03/07 Due: 07/03/08

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03478683 Org: User:
Start: 06/25/18 End: 03/14/19 Due: 03/14/20

A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01962454 Org: User:
Start: 05/05/14 End: 03/20/15 Due: 03/20/16

A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo

Phase: N/A Priority: Normal
NCT ID: NCT02948881 Org: User:
Start: 08/31/05 End: 07/31/07 Due: 07/31/08

Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00698516 Org: User:
Start: 07/31/08 End: 05/31/10 Due: 05/31/11

Regulatory TYKERB® Tablets PMS

Phase: N/A Priority: Normal
NCT ID: NCT00975988 Org: User:
Start: 01/31/10 End: 07/31/14 Due: 07/31/15

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00430781 Org: User:
Start: 11/30/06 End: 07/31/11 Due: 07/31/12

Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01435993 Org: User:
Start: 09/08/11 End: 01/23/12 Due: 01/23/13

Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00061308 Org: User:
Start: 12/31/02 End: - Due: -

Trobalt™ Products Risk Survey

Phase: N/A Priority: Normal
NCT ID: NCT01721213 Org: User:
Start: 09/30/12 End: 12/31/13 Due: 12/31/14

Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT02223637 Org: User:
Start: 09/30/14 End: 12/08/17 Due: 12/08/18

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.

Phase: N/A Priority: Normal
NCT ID: NCT01587716 Org: User:
Start: 04/23/12 End: 07/30/12 Due: 07/30/13

Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)

Phase: N/A Priority: Normal
NCT ID: NCT03457701 Org: User:
Start: 07/30/19 End: 07/05/22 Due: 07/05/23

A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain

Phase: N/A Priority: Normal
NCT ID: NCT01266967 Org: User:
Start: 02/28/11 End: 11/30/12 Due: 11/30/13

Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)

Phase: N/A Priority: Normal
NCT ID: NCT00346775 Org: User:
Start: 05/01/06 End: 06/29/06 Due: 06/29/07

Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00455572 Org: User:
Start: 05/11/07 End: 08/08/13 Due: 08/08/14

Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02992743 Org: User:
Start: 12/06/16 End: 03/22/22 Due: 03/22/23